论文部分内容阅读
抗病毒治疗是对乙型肝炎病毒 (ＨＢＶ)感染者的病因治疗 ,α干扰素 (ＩＦＮα)是目前疗效较肯定的药物。患者体内ＨＢＶＤＮＡ水平对治疗效果有影响 ;患者体内干扰素抗体 ,特别是抗体类型和出现的时间也可影响治疗效果。我们测定 38例慢性乙型肝炎 (ＣＢＨ )患者治疗前后血清干
Antiviral therapy is the etiological treatment of hepatitis B virus (HBV) infection, interferon (IFNα) is the current efficacy of certain drugs. The level of HBVDNA in the patient affects the therapeutic effect; interferon antibodies in the patient’s body, particularly the type and timing of the antibody, can also affect the therapeutic effect. We measured serum levels of 38 patients with chronic hepatitis B (CBH) before and after treatment